Diabetes and the menopause

Maturitas

Volumn 63, Issue 3, 2009, Pages 200-203

  Wedisinghe, Lilantha ^a   Perera, Mahesh ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Diabetes; Hormone replacement therapy; Menopausal symptoms; Menopause

Indexed keywords

CONJUGATED ESTROGEN; DYDROGESTERONE PLUS ESTRADIOL; ESTRADIOL; GESTAGEN; GLUCAGON DERIVATIVE; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE;

ABDOMINAL AORTA ANEURYSM; BONE METABOLISM; BREAST CANCER; CANCER RISK; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; DIABETIC PATIENT; DRUG BLOOD LEVEL; DRUG MEGADOSE; ESTROGEN DEFICIENCY; GLUCOSE HOMEOSTASIS; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LOW DRUG DOSE; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PATHOPHYSIOLOGY; POSTMENOPAUSE; REVIEW; STROKE; VENOUS THROMBOEMBOLISM;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; NEOPLASMS; POSTMENOPAUSE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 67649479224     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.04.005     Document Type: Review

References (49)

1. World Health Organisation. http://apps.who.int/infobase/report.aspx?rid=112&ind=DIA accessed May 5, 2009.
2. Department of Health. Series DH2. No. 30. Mortality statistics cause review of the registrar general on deaths by cause, sex and age, in England and Wales, London; 2003.
3. Salpeter S.R., Walsh J.M.E., Ormiston T.M., Greyber E., Buckley N.S., and Salpeter E.E. Meta-analysis: effect of hormone replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 8 (2006) 538-554
4. Huston S.A., Kirking D.M., and Shimp L.A. Use intentions and beliefs about hormone replacement therapy in women with and without diabetes. Maturitas 55 (2006) 58-68
5. Lee D.H., Folsom A.R., and Jacobs D.R. Dietary iron intake and type 2 diabetes in postmenopausal women: the Iowa women's health study. Diabetologia 47 (2004) 185-194
6. Pereira M.A., Parker E.D., and Folsom A.R. Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28812 postmenopausal women. Arch Intern Med 166 (2006) 1311-1316
7. Tinker L.F., et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomised controlled dietary modification trial. Arch Intern Med 168 July (14) (2008) 1500-1511
8. Korytkowski M.T., Krug E.I., Daly M.A., Deriso L., Wilson J.W., and Winters S.J. Does androgen excess to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?. Metabolism 54 (2005) 1626-1631
9. Ding E.L., Song Y., Manson J.E., Rifai N., Buring J.E., and Liu S. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia 50 (2007) 2076-2084
10. Kanaya A., Herrington D., Vittinghoff E., et al. Glycaemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. Ann Intern Med 138 (2003) 1-9
11. Margolis K.L., Bonds D.E., Rodabough R.J., et al. Effects of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47 (2004) 1175-1187
12. Kernohan A.F.B., Sattar N., Hilditch T., et al. Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes. Clin Endocrinol 66 (2007) 27-34
13. Cagnacci A., Soldani R., Cariero P., Paoletti A., Fioretti P., and Melis G. Effects of low doses of transdermal 17β estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74 (1992) 1396-1400
14. Notelovitz M., Johnson M., Smith S., and Kitchens C. Metabolic hormonal effects of 25 mg and 50 mg of 17β estradiol implants in surgically menopausal women. Obstet Gynecol 70 (1987) 749-754
15. Lobo R.A., Picker J.H., Wild R.A., Walsh B., and Hirvonen E. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol 84 (1994) 987-995
16. Ajabar L.N., Tsai C.C., Vela P., and Yen S.S.C. Effects of exogenous estrogen on carbohydrate metabolism in postmenopausal women. Am J Obstet Gynecol 113 (1972) 383-387
17. Notelovitz M. Metabolic effects of conjugated estrogen glucose tolerance. S Afr Med J 48 (1974) 2599-2603
18. Godsland I.F. Oestrogens and insulin secretion. Diabetologia 48 (2005) 2213-2220
19. Lindheim S.R., Presser S.C., Ditkoff E.C., Vijod M.A., Stancck F.Z., and Lobo R.A. A possible bimodal effect of strong insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 60 (1993) 664-667
20. Goldsland I.F., Gangar K., Walton C., et al. Insulin resistance, secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 42 (1993) 846-853
21. Luotola H., Pyorala T., and Loikkanen M. Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in postmenopausal women. Maturitas 8 (1986) 245-253
22. Godsland I.F., Manassiev N.A., Felton C.V., et al. Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women. Clin Endocrinlol 60 (2004) 541-549
23. Dansuk R., Unal O., Karsidag K.Y., and Turan C. Valuation of the effects of various gestagens on insulin sensitivity, using homeostatic model assessment, in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol 20 (2005) 1-5
24. Borissova A.M., Tankova T., Kamenova P., et al. Effect of hormone replacement therapy on insulin secretion and insulin sensitivity in postmenopausal diabetic women. Gynecol Endocrinol 16 (2002) 67-74
25. Rossouw J.E., et al. Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
26. Fineberg S.E. Glycaemic control and hormone replacement therapy: implications of the postmenopausal estrogen/progestogen intervention (PEPI) study. Drugs Aging 17 (2000) 453-461
27. Perera M., Sattar N., Petrie J.R., et al. The effects of transdermal oestradiol in combination with oral norethisterone on lipoproteins, coagulation and endothelial markers in postmenopausal women with type 2 diabetes: a randomized placebo controlled study. J Clin Endocrinol Metab 86 (2001) 1140-1143
28. McKenzie J., Jaap A.J., Gallacher S., et al. Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?. Clin Endocrinol (Oxf) 59 December (6) (2003) 682-689
29. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 (2004) 1701-1712
30. Nicodemus K.K., Kristin K., and Folsom A.R. Type 1 and type 2 diabetes and incident of hip fractures in postmenopausal women. Diabetes Care 24 (2001) 1192-1197
31. Perera M., Petrie J.R., Hillier C., et al. Hormone replacement therapy can augment vascular relaxation in postmenopausal women with type 2 diabetes. Hum Reprod 17 (2002) 497-502
32. Howard B.V., Hsia J., Ouyand P., et al. Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance. Circulation 110 (2004) 201-206
33. Hayward C.S., Samaras K., Campbell L., and Kelly R.P. Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women. Am J Hypertens 14 (2001) 699-703
34. Scott A.R., Dhindsa P., Forsyth J., et al. Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes. Diabetes Obes Metab 6 (2004) 16-22
35. Hulley S., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-613
36. Petitti D.B. Hormone replacement therapy and heart disease prevention: experimentation trumps observation. JAMA 280 (1998) 650-652
37. Mosca L., Collins P., Herrington D.M., et al. AHA scientific statement: hormone replacement therapy and cardiovascular disease-a statement for healthcare professionals from the American heart association. Circulation 104 (2001) 499
38. Rossouw J.E., Prentice R.L., Manson J.E., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 (2007) 1465-1477
39. Rees M., Stevenson J., Hope S., Rozenberg S., and Palacios S. Management of the menopause. 5th ed. (2009), British Menopause Society Publications Ltd. and Royal Society of Medicine Press, London
40. Lederle F.A., Larson J.C., Margolis K.L., et al. Abdominal aortic aneurysm events in women's health initiative: cohort study. BMJ 337 (2008) 1724-1726
41. Tsai A.W., Cushman M., Rosamond W.D., et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism aetiology. Arch Intern Med 162 (2002) 1182-1189
42. Canonico M., Plu-Bureau G., Lowe G.D., and Scarabin P.Y. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 336 (2008) 1227-1231
43. Grady D., Gebretsadik T., Kerlikowske K., et al. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85 (1995) 304-313
44. McPherson C.P., Sellers T.A., Potter J.D., et al. Reproduction factors and risk of endometrial cancer: the Iowa women's health study. Am J Epidemiol 143 (1996) 1195-1202
45. Gompel A., Rozeneberg S., and Barlow D.H. The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy. Maturitas 61 (2008) 227-232
46. Hu F.B., Manson J.E., Liu S., et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91 (1999) 542-547
47. Nilsen T.I., and Vatten L.J. Prospective study of colorectal cancer risk and physical activity, diabetes, hyperinsulinemia hypothesis. Br J Cancer 84 (2001) 417-422
48. Svacina S., Matoulek M., Svobodova S., et al. Gastrointestinal tract cancer and diabetes mellitus. Vnitr Lek 50 (2004) 386-391
49. Khoo C.L., and Perera M. Diabetes and the menopause. J Br Menopause Soc 11 (2005) 1-6